identification pre-leukaemic haematopoietic stem cells acute leukaemia 
acute myeloid leukaemia aml cell origin nature biological consequences initiating lesions order subsequent mutations remain poorly understood aml typically diagnosed without observation pre-leukaemic phase highly purified haematopoietic stem cells hscs progenitor mature cell fractions blood aml patients found contain recurrent dnmt3a mutations dnmt3amut high allele frequency without coincident npm1 mutations npm1c present aml blasts dnmt3amut-bearing hscs showed multilineage repopulation advantage non-mutated hscs xenografts establishing identity pre-leukaemic hscs pre-leukaemic hscs found remission samples indicating survive chemotherapy therefore dnmt3amut arises early aml evolution probably hscs leading clonally expanded pool pre-leukaemic hscs aml evolves findings provide paradigm detection treatment pre-leukaemic clones acquisition additional genetic lesions engenders greater therapeutic resistance 
